Daily Archives: September 5, 2022
Consensus Statement | Preoperative management of cardiovascular medications.
5 Sep, 2022 | 14:42h | UTCRelated:
Preoperative Management of Medications for Neurologic Diseases – Mayo Clinic Proceedings
Preoperative Management of Surgical Patients Using Dietary Supplements – Mayo Clinic Proceedings
Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
Preoperative Cardiac Risk Assessment – Mayo Clinic Proceedings
Preoperative Evaluation Before Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Cardiac Risk Reduction in Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
RCT | Efficacy of prednisolone for Bell Palsy in children.
5 Sep, 2022 | 14:39h | UTCEfficacy of Prednisolone for Bell Palsy in Children: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial – Neurology (link to abstract – $ for full-text)
Commentary on Twitter
In children with Bell's palsy the vast majority recover without treatment. The study, although underpowered, does not provide evidence that early treatment with prednisolone improves complete recovery.https://t.co/QUVA14vZDG
— Santi Mintegi (@MintegiSanti) August 29, 2022
RCT | Bronchodilators don’t improve smoking-related respiratory symptoms in people without COPD.
5 Sep, 2022 | 14:40h | UTCNews Release: Bronchodilators don’t improve smoking-related respiratory symptoms in people without COPD – NIH News Releases
Original Study: Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
This trial involving symptomatic, tobacco-exposed persons with preserved lung function onspirometry showed no benefit to the use of dual bronchodilator therapy. https://t.co/kXqXHMl2xx pic.twitter.com/KAMuI4Jajo
— NEJM (@NEJM) September 4, 2022
Perspective | Science, competing values, and trade-offs in public health — the example of Covid-19 and masking.
5 Sep, 2022 | 14:37h | UTC
FDA authorizes updated COVID boosters from Moderna and Pfizer.
5 Sep, 2022 | 14:36h | UTCFDA authorizes updated COVID boosters from Moderna and Pfizer – CIDRAP
FDA News Release: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose – U.S. Food & Drug Administration
Opinion | People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information.
5 Sep, 2022 | 14:35h | UTC
Cohort Study | Habitual alcohol intake and risk of atrial fibrillation in young adults.
5 Sep, 2022 | 14:33h | UTCHabitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea – JAMA Network Open
Invited Commentary: Self-reported Alcohol Consumption and Risk of Atrial Fibrillation – JAMA Network Open
European guideline (EuroGuiDerm) on atopic eczema – Part II | Non-systemic treatments and treatment recommendations for special AE patient populations.
5 Sep, 2022 | 14:32h | UTC
A pilot study showed GnRH replacement could improve cognition in Down syndrome.
5 Sep, 2022 | 14:34h | UTCGnRH replacement rescues cognition in Down syndrome – Science (link to abstract – $ for full-text)
News Release: A therapy found to improve cognitive function in patients with Down syndrome – INSERM
Commentary: A Hormone May Boost Cognition in Down Syndrome – Scientific American
Joint Position Paper | Organ donation after circulatory determination of death in India.
5 Sep, 2022 | 14:31h | UTC
Review | Right ventricular function across the spectrum of health and disease.
5 Sep, 2022 | 14:30h | UTCRight ventricular function across the spectrum of health and disease – Heart
Commentary on Twitter
Right ventricular function across the spectrum
of health and disease https://t.co/3i9iiddsyV #echofirst #Cardiotwitter #CardioEd #MedEd #CardioTwitteros pic.twitter.com/Q219nvnu6v— Sergio Moreno M (@Serginho1409) July 11, 2022
Under a http://creativecommons.org/licenses/by-nc/4.0/ license
Brief Review | What’s new in pediatric ventilator liberation?
5 Sep, 2022 | 14:29h | UTCWhat’s new in paediatric ventilator liberation? – Intensive Care Medicine
Commentary on Twitter
Pediatric ventilator liberation, update
⚙️ assess/adjustment of MV & sedation
⚙️ prepare
⚙️ extubate
⚙️ support
Many questions unanswered! peri-extubation steroids, criteria for NIV after extubation, post-extubation rescue HFNC vs CPAP.#PedsICU #FOAMcc
🖇️ https://t.co/MGPStTvZh2 pic.twitter.com/AySzk9blS5— Intensive Care Medicine (@yourICM) September 2, 2022
The Australian obesity management algorithm: a simple tool to guide the management of obesity in primary care.
5 Sep, 2022 | 14:31h | UTC
5-year follow-up of a RCT | Five-year outcomes of FOLFIRINOX vs. Gemcitabine as adjuvant therapy for pancreatic cancer.
5 Sep, 2022 | 14:26h | UTCFive-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)
Commentary on Twitter
Updated 5-year results of the Unicancer PRODIGE 24/CCTG PA6 trial confirmed the significant improvement in all outcomes, including overall survival, with mFOLFIRINOX regimen compared to gemcitabine in adjuvant setting for pts w #pancreaticcancer. https://t.co/rCFntho0f1 #GICSM pic.twitter.com/VAVBD7o6kc
— JAMA Oncology (@JAMAOnc) September 1, 2022
RCT | Maintaining continuous endotracheal cuff pressure control through an automated electronic device did not reduce the incidence of ventilator-associated respiratory infection.
5 Sep, 2022 | 14:25h | UTC
Brief Review | Monitoring of renal perfusion.
5 Sep, 2022 | 14:27h | UTCMonitoring of renal perfusion – Intensive Care Medicine
Commentary on Twitter
Hypoperfusion long considered among main predisposing factors for #AKI in #ICU; this recently challenged ie #sepsis. How to monitor renal perfusion?
🫘 RI doppler-based renal resistive index/RI change
🫘 CEUS
🫘 RVI renal venous impedance index#FOAMcc
🖇️ https://t.co/Eejruztegw pic.twitter.com/KLCksRjx6U— Intensive Care Medicine (@yourICM) September 3, 2022
Review | The prevention and treatment of nausea and vomiting during tumor therapy.
5 Sep, 2022 | 14:23h | UTCThe Prevention and Treatment of Nausea and Vomiting During Tumor Therapy – Deutsches Ärzteblatt International
Related:
SEOM clinical guideline emesis (2021) – Clinical and Translational Oncology
Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes – Drugs & Aging (if the link is paywalled, try this one)
RCT | Reduction of nonoperative time using the induction room, parallel processing, and Sugammadex.
5 Sep, 2022 | 14:24h | UTC
RCT | Comparison of rhomboid intercostal block, erector spinae plane block, and serratus plane block on analgesia for video-assisted thoracic surgery.
5 Sep, 2022 | 14:22h | UTC
Review | Small intestinal bacterial overgrowth breath testing in gastroenterology: clinical utility and pitfalls.
5 Sep, 2022 | 14:21h | UTC
30-month follow-up analysis of a RCT | Pembrolizumab vs. placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma.
5 Sep, 2022 | 14:20h | UTCInvited Commentary: Adjuvant immunotherapy for renal cell carcinoma – The Lancet Oncology
Original Article: Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma – New England Journal of Medicine
RCT | Telaglenastat failed to improve the efficacy of Cabozantinib in patients with advanced renal cell carcinoma.
5 Sep, 2022 | 14:19h | UTCEfficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Commentary on Twitter
https://twitter.com/JAMAOnc/status/1565368902674178048
Nonalcoholic fatty liver disease: review of management for primary care providers.
5 Sep, 2022 | 14:18h | UTC
Volatile anesthetics for ICU sedation: the future of critical care or niche therapy?
5 Sep, 2022 | 14:16h | UTC
Commentary on Twitter
Volatile anesthetics for #ICU sedation
➡️ ventilators adaptable to deliver
➡️ effective even in #ARDS
➡️ rapid on/offset, no accumulation
➡️ analgesic effect: opioid-sparing?
➡️ may preserve spont breathing
➡️ immunomodulatory/organ-protective effects?
🖇️ https://t.co/XZAJgElwYs pic.twitter.com/dTpsaued8V— Intensive Care Medicine (@yourICM) September 4, 2022
Systematic Review | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
5 Sep, 2022 | 14:15h | UTC